Hospital admissions for cardiovascular diseases decline on days with major snowfalls compared to days with no snowfall, but they jump by 23% two days later, according to a new study led by researchers from Harvard T.H. Chan ...
Jan 30, 2017
0
0
A study led by Massachusetts General Hospital (MGH) and Icahn School of Medicine at Mount Sinai (ISSMS) investigators has linked, for the first time in humans, activity in a stress-sensitive structure within the brain to ...
Jan 11, 2017
0
533
A genetic test recently implemented at UPMC Presbyterian can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients, according to the results of a large ...
Nov 16, 2016
0
2
The large multinational randomized BIONICS study found that a novel ridaforolimus-eluting stent (BioNIR) was non-inferior to a zotarolimus-eluting stent (Resolute) for one-year clinical outcomes in a broad, less selected ...
Oct 31, 2016
0
0
(HealthDay)—The addition of lixisenatide to usual care does not impact the rate of major cardiovascular events or other serious adverse events among patients with type 2 diabetes and a recent acute coronary syndrome, according ...
Dec 03, 2015
0
0
(HealthDay)—For patients with type 1 diabetes, regular physical activity (PA) is beneficial for glycemic control, diabetes-linked comorbidities, and cardiovascular risk factors, without apparent increase in adverse events, ...
Jun 12, 2015
0
15
(HealthDay)—Dietary supplementation with ω-3 polyunsaturated fatty acids or macular xanthophylls do not seem to reduce the risk of cardiovascular disease (CVD) in older adults with age-related macular degeneration, according ...
Mar 21, 2014
0
0
(Medical Xpress)—Physicians who treat heart disease patients often wonder how to determine if their patients are at risk of another heart attack or stroke. Now, University of Florida researchers and their colleagues have ...
Sep 10, 2013
0
0
Despite their well-documented benefits, statins, drugs used to lower cholesterol, are commonly discontinued in routine care. Statin discontinuation has been linked to increased risk for cardiovascular events and death in ...
Apr 01, 2013
0
0
(HealthDay)—Metformin therapy significantly reduces cardiovascular events in high-risk patients with type 2 diabetes compared to treatment with glipizide, according to a study published online Dec. 10 in Diabetes Care.
Jan 08, 2013
0
0
